Evidence Hub

Epicardial appendage ooze causing pericardial tamponade after left atrial appendage device implantation

K. Phillips, Christopher Smith, M. Butler, A. Taylor, T. Hall

HeartRhythm Case Reports, 2018

3 citations

Abstract

Pericardial tamponade is a serious complication of left atrial appendage (LAA) device occlusion reported in approximately 1%–3% of contemporary implant registries.1, 2 The root cause of most pericardial effusions within 7 days of the procedure has generally been determined to be cardiac perforation due to transseptal puncture or manipulation of delivery equipment or the closure device.3 The cause of some pericardial effusions, however, has not been clearly defined.3 This case outlines a novel etiology for delayed pericardial effusion and cardiac tamponade postimplant of the WATCHMAN LAA occlusion device (Boston Scientific, Natick, MA).

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free